Elina Alaterre
Overview
Explore the profile of Elina Alaterre including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
94
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Alaterre E, Ovejero S, Bret C, Dutrieux L, Sika D, Fernandez Perez R, et al.
Blood
. 2024 Apr;
144(5):496-509.
PMID: 38643512
Plasma cells (PCs) are highly specialized cells representing the end stage of B-cell differentiation. We have shown that PC differentiation can be reproduced in vitro using elaborate culture systems. The...
2.
Chemlal D, Varlet E, Machura A, Ovejero S, Requirand G, Robert N, et al.
Leukemia
. 2023 Aug;
37(9):1925-1928.
PMID: 37532787
No abstract available.
3.
Salma M, Alaterre E, Moreaux J, Soler E
Epigenetics Chromatin
. 2023 Jun;
16(1):23.
PMID: 37312221
Background: High-throughput sequencing (HTS) offers unprecedented opportunities for the discovery of causative gene variants in multiple human disorders including cancers, and has revolutionized clinical diagnostics. However, despite more than a...
4.
Ovejero S, Viziteu E, Dutrieux L, Devin J, Lin Y, Alaterre E, et al.
Front Immunol
. 2022 Dec;
13:983181.
PMID: 36569948
Multiple myeloma (MM) is a hematologic cancer characterized by accumulation of malignant plasma cells in the bone marrow. To date, no definitive cure exists for MM and resistance to current...
5.
Duroux-Richard I, Gagez A, Alaterre E, Letestu R, Khalifa O, Jorgensen C, et al.
Front Immunol
. 2022 Nov;
13:983771.
PMID: 36325355
Clinical Trial Registration: ClinicalTrials.gov, identifier NCT01370772.
6.
Alaterre E, Ovejero S, Herviou L, de Boussac H, Papadopoulos G, Kulis M, et al.
Theranostics
. 2022 Feb;
12(4):1715-1729.
PMID: 35198065
Human multiple myeloma (MM) cell lines (HMCLs) have been widely used to understand the molecular processes that drive MM biology. Epigenetic modifications are involved in MM development, progression, and drug...
7.
Haas M, Caron G, Chatonnet F, Manenti S, Alaterre E, Devin J, et al.
Blood
. 2022 Feb;
139(15):2316-2337.
PMID: 35108359
The differentiation of B cells into plasmablasts (PBs) and then plasma cells (PCs) is associated with extensive cell reprogramming and new cell functions. By using specific inhibition strategies (including a...
8.
Gagez A, Paul F, Alaterre E, Gouilleux-Gruart V, Tuaillon E, Lepretre S, et al.
Leuk Lymphoma
. 2021 Nov;
62(13):3160-3169.
PMID: 34806520
Angiogenesis is in a constant balance between pro and anti-angiogenic factors. Neoangiogenesis, implicated in metastatic spreading is characterized in solid cancers, but fairly new in chronic lymphocytic leukemia (CLL). We...
9.
RNA-Sequencing-Based Transcriptomic Score with Prognostic and Theranostic Values in Multiple Myeloma
Alaterre E, Vikova V, Kassambara A, Bruyer A, Robert N, Requirand G, et al.
J Pers Med
. 2021 Oct;
11(10).
PMID: 34683129
Multiple myeloma (MM) is the second most frequent hematological cancer and is characterized by the clonal proliferation of malignant plasma cells. Genome-wide expression profiling (GEP) analysis with DNA microarrays has...
10.
Dausset C, Bornes S, Miquel S, Kondjoyan N, Angenieux M, Nakusi L, et al.
Sci Rep
. 2020 Oct;
10(1):17074.
PMID: 33051479
GYNOPHILUS (Lcr REGENERANS) is a live biotherapeutic product (LBP) aimed at restoring the vaginal microbiome and contains the live biotherapeutic microorganism Lactobacillus rhamnosus Lcr35. In this study, the LBP formulation...